Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of non-feminizing estrogens as treatment for retinal vascular diseases

Use of non-feminizing estrogens as treatment for retinal vascular diseases

US Patent 7488723 · Granted Feb 10, 2009

Estimated economic value: $342,083,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating ophthalmic diseases using NPR-B agonists2017
Methods of treating ophthalmic diseases using NPR-B agonists2015
NPR-B agonists2013
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and g2012
RNAi inhibition of CTGF for treatment of ocular disorders2010
Use of inhibitors of Jun N-terminal kinases to treat glaucoma2010
Method of treating glaucoma2009
RNAi inhibition of CTGF for treatment of ocular disorders2009
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma2009
Use of non-feminizing estrogens as retinoprotective agents for the treatment of 2008
Agents which regulate, inhibit, or modulate the activity and/or expression of co2008
Use of AP-1 activators to treat glaucoma and ocular hypertension2006